4
MARKET OVERVIEW
Provides a snapshot of current market scenario, value chain context, and factors impacting competitive intensity.
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNTIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Outlines emerging trends, technology impact, and regulatory signals affecting growth trajectory and stakeholder decisions.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMIC OUTLOOK
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN THE CONJUGATE VACCINES MARKET
5.5.1
AVERAGE SELLING PRICE TREND OF VACCINES, BY KEY PLAYER, 2023–2025
5.5.2
AVERAGE SELLING PRICE TREND OF VACCINES, BY DISEASE INDICATION, 2023–2025
5.5.3
AVERAGE SELLING PRICE TREND OF VACCINES, BY REGION, 2021–2023
5.6.1
IMPORT SCENARIO (HS CODE 300220)
5.6.2
EXPORT SCENARIO (HS CODE 300220)
5.7
KEY CONFERENCES AND EVENTS, 2025–2026
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.9
INVESTMENT AND FUNDING SCENARIO
5.9.1
VC/PRIVATE EQUITY INVESTMENT TRENDS & STARTUP LANDSCAPE
5.10
IMPACT OF 2025 US TARIFF – CONJUGATE VACCINES MARKET
5.10.3
PRICE IMPACT ANALYSIS
5.10.5
IMPACT ON END-USE INDUSTRIES
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1
KEY EMERGING TECHNOLOGIES
6.1.1
RECOMBINANT TECHNOLOGY
6.1.2
CONJUGATION TECHNOLOGY
6.1.3
VIRAL VECTOR TECHNOLOGY
6.2
COMPLEMENTARY TECHNOLOGIES
6.2.1
ENCAPSULATION & DELIVERY TECHNOLOGY
6.2.2
AUTOMATION & CONTROL
6.3
ADJACENT TECHNOLOGIES
6.3.1
SINGLE-USE TECHNOLOGY
6.3.2
CELL LINE DEVELOPMENT
6.4
TECHNOLOGY/PRODUCT ROADMAP
6.7
IMPACT OF AI/GEN AI ON CONJUGATE VACCINES MARKET
6.7.1
TOP USE CASES AND MARKET POTENTIAL
6.7.2
CASE STUDIES OF AI IMPLEMENTATION IN THE CONJUGATE VACCINES MARKET
6.7.3
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.7.4
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN THE CONJUGATE VACCINES MARKET
7
SUSTAINABILITY AND REGULATORY LANDSCAPE
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
7.2
SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
7.3
CERTIFICATIONS, LABELING, ECO-STANDARDS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
CONJUGATE VACCINES MARKET, BY DISEASE INDICATION
Market Size, Volume & Forecast – USD Million
9.4
MENINGOCOCCAL DISEASE
9.5
OTHER DISEASE INDICATIONS
10
CONJUGATE VACCINES MARKET, BY TYPE
Market Size, Volume & Forecast – USD Million
10.2
MULTIVALENT VACCINES
11
CONJUGATE VACCINES MARKET, BY END USER
Market Size, Volume & Forecast – USD Million
12
CONJUGATE VACCINES MARKET, BY REGION, 2023-2030 (USD MILLION)
12.2.3
MACROECONOMIC OUTLOOK OF NORTH AMERICA
12.3.8
MACROECONOMIC OUTLOOK OF EUROPE
12.4.6
REST OF ASIA PACIFIC
12.4.7
MACROECONOMIC OUTLOOK OF ASIA PACIFIC
12.5.3
REST OF LATIN AMERICA
12.5.4
MACROECONOMIC OUTLOOK OF LATIN AMERICA
12.6.2
REST OF MIDDLE EAST
12.6.3
MACROECONOMIC OUTLOOK OF MIDDLE EAST
12.7.1
MACROECONOMIC OUTLOOK OF AFRICA
13.2
KEY PLAYERS STRATEGY/ RIGHT TO WIN
13.3
REVENUE ANALYSIS, 2022-2024
13.4
MARKET SHARE ANALYSIS,
13.5
COMPANY EVALUATION MATRIX: KEY PLAYERS
13.5.5
COMPANY FOOTPRINT: KEY PLAYERS,
13.5.5.1
COMPANY FOOTPRINT
13.5.5.2
REGION FOOTPRINT
13.5.5.3
DISEASE INDICATION FOOTPRINT
13.6
COMPANY EVALUATION MATRIX: START-UPS/SMES,
13.6.1
PROGRESSIVE COMPANIES
13.6.2
RESPONSIVE COMPANIES
13.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
13.6.5.1
DETAILED LIST OF KEY STARTUPS/ SMES
13.6.5.2
COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
13.7
COMPETITIVE SCENARIO
13.7.3
OTHER DEVELOPMENTS
13.8
BRAND/ PRODUCT COMPARATIVE ANALYSIS
13.9
VALUATION AND FINANCIAL METRICS
14.1.2
MERCK & CO., INC (US)
14.1.5
SERUM INSTITUTE OF INDIA (INDIA)
14.1.6
DAIICHI SANKYO COMPANY LIMITED (JAPAN)
14.1.7
PANACEA BIOTEC (INDIA)
14.1.8
BIOLOGICAL E LIMITED (INDIA)
15.1.1.1
KEY SOURCES OF SECONDARY DATA
15.1.1.2
KEY OBJECTIVES OF SECONDARY DATA
15.1.2.1
BREAKDOWN OF PRIMARY INTERVIEWS
15.1.2.2
KEY OBJECTIVES OF PRIMARY RESEARCH
15.2
MARKET SIZE ESTIMATION
15.2.1
CONJUGATE VACCINES MARKET SIZE ESTIMATION
15.2.1.1
COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH)
15.2.1.2
MNM REPOSITORY ANALYSIS
15.2.1.3
SECONDARY ANALYSIS
15.2.1.4
PRIMARY RESEARCH
15.2.1.4.1
INSIGHTS FROM PRIMARY EXPERTS
15.3
MARKET GROWTH RATE PROJECTIONS
15.6
RESEARCH ASSUMPTIONS
15.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
16.2
KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
16.3
AVAILABLE CUSTOMIZATIONS
Growth opportunities and latent adjacency in Conjugate Vaccines Market